ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,152 | 3,934 | 5,014 | 2,471 | 1,346 |
| Depreciation Amortization | 6,706 | 22,343 | 16,531 | 10,565 | 4,609 |
| Income taxes - deferred | -735 | -8,911 | -1,084 | -435 | -81 |
| Accounts receivable | -802 | -23,963 | -25,545 | -13,630 | -549 |
| Other Working Capital | -3,862 | -9,927 | -15,179 | -5,099 | 2,265 |
| Other Operating Activity | 4,070 | 43,996 | 35,653 | 20,434 | 3,379 |
| Operating Cash Flow | $6,529 | $27,472 | $15,390 | $14,306 | $10,969 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,138 | -4,566 | -3,177 | -2,088 | -1,369 |
| Purchase Sale Intangibles | -50,956 | -144,494 | -144,494 | -144,494 | -84,182 |
| Other Investing Activity | -50,956 | -144,494 | -144,494 | -144,494 | -84,182 |
| Investing Cash Flow | $-53,094 | $-149,060 | $-147,671 | $-146,582 | $-85,551 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 30,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 25 | 1,570 | 1,362 | 504 | 144 |
| Common Stock Repurchased | N/A | -2,622 | -2,622 | -2,622 | -2,500 |
| Other Financing Activity | 0 | 323 | 13 | -275 | 1 |
| Financing Cash Flow | $30,025 | $-729 | $-1,247 | $-2,393 | $-2,355 |
| Beginning Cash Position | 32,367 | 154,684 | 154,684 | 154,684 | 154,684 |
| End Cash Position | 15,827 | 32,367 | 21,156 | 20,015 | 77,747 |
| Net Cash Flow | $-16,540 | $-122,317 | $-133,528 | $-134,669 | $-76,937 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,529 | 27,472 | 15,390 | 14,306 | 10,969 |
| Capital Expenditure | -2,138 | -4,566 | -3,177 | -2,088 | -1,369 |
| Free Cash Flow | 4,391 | 22,906 | 12,213 | 12,218 | 9,600 |